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Introduction
Fibrosing alveolitis (FA) is a severe adverse effect after 
treatment of the thorax with ionizing irradiation (IR). Its 
final stage is called pulmonary fibrosis (PF). The disease 
has an inflammatory component but also involves disturbed 
regulation of cell survival, proliferation and differentiation. 
These changes are mediated by a number of pro-fibrogenic 
cytokines and growth factors such as members of the FGF 
(fibroblast growth factor) family, TNFα (tumor necrosis 
factor alpha), TGFβ (transforming growth factor beta), 
PDGF (platelet-derived growth factor) and many more 
(Crouch 1990; Kovacs 1991; Kovacs & DiPietro 1994; 
Stone et al. 2004; Fleckenstein et al. 2007).
FA usually occurs after a latency period of several 
weeks or months. During this latency period, no general 
disturbance to the lung architecture can be detected with 
light microscopy (Kasper et al. 1994); however, changes in 
gene regulation have been detected in a rat model. Whereas 
the transcription factor NF-κB (nuclear factor kappaB) is 
continuously up-regulated (Haase et al. 2003), other tran-
scription factors, such as Sp1 (stimulating protein 1) (Haase 
et al. 2000) and AP-1 (activator protein 1) (Haase et al. 
2008), are inactivated during this latency period before the 
onset of FA. The inactivation of these important regulatory 
factors might lead to a defective production of protective 
proteins resulting in a disturbance of cellular functions 
such as proliferation, differentiation and the production of 
matrix proteins. One of the protective genes known to be 
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Summary 
Ionizing radiation (IR) leads to fibrosing alveolitis (FA) after a lag period of several weeks to months. In a rat model, FA 
starts at 8 weeks after IR. Before that, at 5.5 weeks after IR, the transcription factors Sp1 (stimulating protein 1) and 
AP-1 (activator protein 1) are inactivated. To find genes/proteins that were down-regulated at that time, differentially 
expressed genes were identified in a subtractive cDNA library and verified by quantitative RT-PCR (reverse transcriptase 
polymerase chain reaction), western blotting and immunohistochemistry (IH). The mRNA of the molecular chaperone 
HSP90AB1 (heat shock protein 90 kDa alpha, class B member 1) was down-regulated 5.5 weeks after IR. Later, when FA 
manifested, HSP90ab1 protein was down-regulated by more than 90% in lung cells with the exception of mast cells. In 
most mast cells of the normal lung, both HSP90ab1 and HSP70, another major HSP, show a very low level of expression. 
HSP70 was massively up-regulated in all mast cells three months after irradiation whereas HSP90AB1 was up-regulated 
only in a portion of mast cells. The strong changes in the expression of central molecular chaperones may contribute to the 
well-known disturbance of cellular functions in radiation-damaged lung tissue. (J Histochem Cytochem 62:355–368, 2014)
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down-regulated is KGF (keratinocyte growth factor) 
(Haase et al. 2008). In line with its protective function, 
studies have shown that KGF treatment ameliorates radiation-
induced lung injury (Yi et al. 1996; Dorr et al. 2002).
The heat shock proteins (HSPs) comprise a large group 
of protective genes that are induced after the induction of 
cellular stressors, such as radiation. These are ubiquitous 
proteins that function as molecular chaperones, which are 
proteins that stabilize partially folded or unfolded proteins, 
or directly facilitate proper protein folding (Lodish et al. 
2004; Wegele et al. 2004). Besides some smaller HSPs, two 
major groups of HSPs have been described: HSP70 and 
HSP90 (Wegele et al. 2004; Young et al. 2004).
HSPs are highly conserved and highly abundant proteins 
(Wegele et al. 2004). HSP90 has been described to be 
essential for cell viability in all eukaryotic cell types 
(Borkovich et al. 1989; Cutforth & Rubin 1994; Sreedhar et 
al. 2003). HSP target proteins comprise proteins of virtually 
all major protein groups, such as receptor proteins, signal-
ing proteins (kinases), polymerases as well as structural 
proteins (Wegele et al. 2004). For example, HSP90 directly 
interacts with protein kinases and thereby influences sev-
eral signal transduction pathways, such as the mitogen-acti-
vated protein kinase (MAPK) (Miyata et al. 2001) and the 
phosphoinositol-3-kinase (PI3K) pathways (Citri et al. 
2006). Members of the HSP70 family are involved in the 
short-term radiation response (Kang et al. 2002). Studies in 
several cell types suggest that HSP70 proteins mediate 
radioresistance (Gordon et al. 1997; Calini et al. 2003; 
Brondani Da Rocha et al. 2004; Matsumoto et al. 2005). 
This is at least partly mediated by the HSP70-induced stim-
ulation of DNA repair, especially base excision repair 
(Bases 2006), by inhibiting the Akt pathway (Machida et al. 
2005) and by inhibiting apoptosis through its interaction 
with Bag4 (Bcl-2 associated athanogene 4) in the cellular 
membrane (Gehrmann et al. 2005). However, HSPs may 
also increase cell death after radiation by stabilizing p53, as 
shown in a human T-cell model (Fukumoto & Kiang 2011). 
Cells with inactivated HSP70 displayed telomere instability 
and a high frequency of spontaneous chromosomal aberra-
tions, indicating a possible role for HSP70 proteins in the 
maintenance of genomic stability (Pandita et al. 2004). By 
stabilizing proteins that arise from mutant genes, HSPs are 
important players in molecular evolution and in the protec-
tion of cancer cells from apoptosis (Rutherford & Lindquist 
1998). In this respect, HSP inhibitors have been tested as 
radiosensitizers. In most studies, HSP inhibitors, such as 
geldanamycin and radicicol, increased cell killing in the 
short-term radiation response (Russell et al. 2003; 
Harashima et al. 2005; Matsumoto et al. 2005).
In pulmonary fibrosis, studies on HSP expression have 
mostly focused on HSP47, which is involved in the process-
ing and secretion of collagen. The expression of the HSP47 
has been shown to be elevated in idiopathic interstitial 
pneumonias and in bleomycin-induced lung injury 
(Razzaque et al. 1998b; Ishii et al. 2003; Kakugawa et al. 
2005). Therapeutic intervention with the antifibrotic drug 
pirfenidone attenuated lung injury and reduced the level of 
HSP47 in many cell types of the lung (Kakugawa et al. 
2004). Until now, no studies exist on the role of the major 
HSPs of the HSP70 and HSP90 groups in radiation-induced, 
long-term tissue damage of the lung.
The aim of this study was to identify potential protective 
genes that are down-regulated before the onset of radiation-
induced FA. Using a combined quantification of western 
blot and immunohistochemistry (IH), we demonstrate in an 
animal model that HSP90ab1 is down-regulated in the radi-
ation-damaged lung in cells other than mast cells. 
Furthermore, we show that, according to our knowledge, 
mast cells are the first cell type described that are able to 
survive with low to non-detectable amounts of HSP90ab1 
and/or HSP70.
Materials & Methods
Animal Model
The right lungs of female Fischer rats (aged, 7 weeks; 
weight, ~120 g) were irradiated with 20 Gy of ionizing radi-
ation, as previously described (Haase et al. 2003). Lungs 
were removed at the indicated time points and either snap-
frozen or fixed in 4% neutral-buffered formaldehyde for 
exactly 24 hr. Animal housing and experiments were 
approved by the local authorities and followed the German 
and international animal welfare regulations. Three animals 
were used for each time point for histological analysis (con-
trol and 3 months after irradiation) and three animals for 
each time point were used for RT-PCR and western blotting 
(0, 4, 6, 8, 12 weeks after IR, for RT-PCR additionally 5.5 
and 6.5 weeks after IR). Since previous histological analy-
ses have shown that the radiation-induced changes were 
distributed uniformly, pieces of lung were chosen randomly 
for the experiments.
Construction of the Subtractive cDNA Library
Messenger-RNA from rat lungs at 4 and 5.5 weeks after 
irradiation was isolated with polyA-coupled magnetic 
beads (Dynal, Life Technologies; Carlsbad, CA). cDNA 
was constructed with the pBluescript II XR cDNA Library 
Construction Kit (Stratagene, Agilent Technologies, Santa 
Clara, CA) according to the manufacturer’s instructions. 
DNA hybridization was done with the formamide-phenol 
emulsion re-association (F-PERT) technique (Gulick & 
Dvorak 1990), with two modifications (Casna et al. 1986): 
the use of 100 ng tester cDNA (driver:tester ratio, 20:1) 
and the reduction of the total incubation volume to 1 ml. 
The obtained clones were partially sequenced with an 
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ABI Prism 310 Sequencer (Applied Biosystems, Life 
Technologies).
Quantitative RT-PCR
Total RNA was isolated with Trizol (Invitrogen, Life 
Technologies). Primer sequences for HSP90ab1 RT-PCR 
were GGCCGGGGTACCAAAGTGAT (forward) and 
TCGCCGGGGAATGAAGAG (reverse). Reverse tran-
scription reactions were performed with the reverse gene-
specific primers. GAPDH (glycerolaldehyde-3-phosphate 
dehydrogenase) RT-PCR was performed as described 
(Haase et al. 2003) and served as a control reaction. By 
comparing the band intensities after different numbers of 
PCR cycles, the linear range of the PCR was determined. 
Bands of ethidium bromide stained gels were quantified 
using the ImageJ software (NIH, Bethesda, MD).
Western Blotting
Cytoplasmic proteins were isolated according to a pub-
lished protocol (Schreiber et al. 1988). Western blotting 
was performed as described (Haase et al. 2003). Anti-
HSP70 (reactive with HSPa1a and HSPa1b) goat polyclonal 
antibody (K-20, Santa Cruz Biotechnology, Dallas, TX) 
and anti-HSP90beta goat polyclonal antibody (D-19, Santa 
Cruz Biotechnology) were both used at a dilution of 1:7500. 
A monoclonal mouse antibody to beta-Actin (A4700, 
1:500; Sigma-Aldrich, St. Louis, MO) served as a loading 
control.
Histological Staining
H&E and (Masson-Goldner) Trichrome stainings were per-
formed using standard protocols (Böck 1989). Peroxidase-
based IH was done as described (Haase et al. 2003). The 
antibodies mentioned in the western blotting methods sec-
tion were used at a dilution of 1:10, in case of labeling of 
bronchiolar epithelium 1:100. For labeling of mast cells in 
light microscopy, a rabbit polyclonal antibody to IκBγ (sc-
201, Santa Cruz Biotechnology) was used at a concentra-
tion of 1:100 (Haase et al. 2004). For immunofluorescence 
(IF) double labeling, the primary anti-HSP antibodies were 
used at a dilution of 1:100 and detected with the tyramide 
signal amplification (TSA) kit (Molecular Probes, Life 
Technologies). For some double labeling experiments (see 
figure legends), polyclonal goat antibodies to HSP70 (sc-
1060) and HSP90ab1 (sc-1057) were used at a dilution of 
1:100 (Santa Cruz Biotechnology). The polyclonal goat pri-
mary antibodies were used with a biotin bridge anti-goat 
antibody (DAKO, Glostrup, Denmark) at a dilution of 1:100 
(10 ng/ml). The mouse monoclonal antibody to mast cell 
tryptase (DAKO) was used at a dilution of 1:100. The 
mouse monoclonal antibody to surfactant protein D 
({SFTPD}sc-59695; Santa Cruz Biotechnology) was used 
at a dilution of 1:70. The rabbit polyclonal antibody to 
aquaporin 5 (A4979; Sigma Aldrich) was used at a dilution 
of 1:70. The nuclei were stained with DAPI (4’,6-diamid-
ino-2-phenylindole, Molecular Probes). Fluorescence 
images were obtained with the laser scanning microscope 
LSM 510 Meta (Zeiss, Oberkochen, Germany) or an SP5 
upright (Leica Microsystems, Wetzlar, Germany). Control 
staining included replacement of the primary antibody with 
non-immune serum of the same species and blocking with 
the peptide against which the antibodies had been raised. 
The pre-diluted primary antibody was incubated for 1 hr at 
room temperature with 4 µg of blocking peptide before add-
ing this solution to the section.
Quantification of Proteins
We had the impression that different cell types had a differ-
ent HSP expression profile after irradiation. Therefore, we 
sought to quantify HSP expression in different cell types at 
one time point as well as over time. Although quantification 
of IH data is a matter of debate, there have been numerous 
examples of reliable quantification of such experiments 
(van der Loos et al. 1994; Matsuo et al. 1995; Taylor & 
Levenson 2006; Walker 2006; Vilmar et al. 2012). The 
major source of variation is staining intensity, which is 
influenced by the multiple steps involved with tissue prepa-
ration. However, there is no doubt that the different staining 
of various cell types within one section represents the real 
expression of proteins provided that the whole section has 
been treated homogenously. We circumvented the problem 
of variation between different tissue samples by a combina-
tion of methods. The quantification of total HSP90ab1/
HSP70 protein content over time was done by western blot-
ting. This was combined with a quantification of the rela-
tive protein expression in different cell types by IH and IF, 
as follows.
Relative amounts of total HSP proteins were determined 
using western blotting in three independent experiments 
with the help of the ImageJ/Fiji software (Schindelin et al. 
2012). Relative intensities (RI) of the bands in control lungs 
were set to 1 and adjusted to the values of the loading con-
trol (β-actin). In order to correlate the contribution of differ-
ent cell types (mast cells versus non-mast cells) to the total 
amount of protein, IF double staining was performed with 
HSP70 or HSP90AB1 and the mast cell marker mast cell 
tryptase (MCT) and recorded with a laser scanning micro-
scope (Leica, LSM SP5). The settings of the laser power 
and gain were adjusted for the HSP recordings such that the 
background staining was approximately zero. From each of 
three independent experiments, three randomly chosen 
fields of 600625 µm2 were analyzed with Fiji software 
(Schindelin et al. 2012). This area contained more than 
1,400 mast cells. For determination of total lung HSP 
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stained sections, the threshold in the MCT stained sections 
were set to 15 which highlighted all lung tissue. With these 
settings, all particles (particle size 0–infinity) were ana-
lyzed and transferred to the region of interest (ROI) man-
ager. This mask was transferred as an overlay to the HSP 
image and the integrated density of the HSP protein in lung 
tissue was determined. In order to determine the portion of 
mast cell HSP, the threshold in the MCT staining was set to 
150, which highlighted only mast cells. Particles with sizes 
of 0.001–infinity were analyzed and treated as described 
above.
Quantification of mast cell numbers was done in sepa-
rate experiments using histological sections (thickness, ~1 
µm) stained with trypan blue using a Zeiss Axioskop micro-
scope equipped with an ocular micrometer. Ten randomly 
chosen fields of 0.6 mm2 were counted in three different 
sections of normal lungs and lungs obtained three months 
after irradiation.
Results
Histopathological Changes in the Irradiated Rat 
Lung
The normal lungs of Fischer rats had alveoli with thin walls 
(Fig. 1A, 1B). Assuming the diameter of a red blood cell to 
be ~7.5 µm, the alveolar walls were usually not thicker than 
about 10–12 µm. Three months after irradiation with 20 Gy 
of IR, FA was detectable (Fig. 1C–1F). Tissue architecture 
had changed considerably. Large amounts of extracellular 
matrix were accumulated as shown by the turquoise color in 
the Trichrome stain (Fig. 1D and 1F). Aggregates of foamy 
macrophages were found in the remaining alveolar spaces 
(arrows in Fig. 1D–F). In addition, a large number of mast 
cells infiltrated the lung tissue (this is demonstrated in later 
figures). These changes started to occur at about 8 weeks 
after irradiation and were distributed focally in the lung, 
covering about 5 to 10% of the total lung tissue except for 
the mast cell infiltration which started at about 6 weeks 
after irradiation and affected the entire irradiated lung tis-
sue. During the time period of this study (up to 3 months 
after irradiation), no areas with cell-free scar tissue as a fea-
ture of full-blown PF were detectable.
Expression of HSP90ab1 mRNA in Irradiated 
Lungs
After irradiation of the right hemithorax of rats with 20 Gy, 
the major transcriptional changes occur between 4 and 5.5 
weeks after IR. Therefore, a subtractive cDNA library was 
constructed that identified mRNAs that were down-regu-
lated at 5.5 weeks compared with that at 4 weeks after IR 
of the lung. In this library, the cDNA of HSP90ab1 was 
identified by DNA sequencing. In order to verify the 
down-regulation of HSP90ab1 mRNA, quantitative 
RT-PCR was performed. These experiments demonstrated 
that the mRNA of HSP90ab1 was down-regulated at 5.5 
weeks after IR and remained repressed below that of the 
control level (Fig. 2A, 2B), with the exception of a peak at 
6.5 weeks after IR. One representative figure of three inde-
pendent experiments is shown. The next step was to exam-
ine whether IR also affected protein expression levels.
Protein Expression of HSP70 and HSP90ab1 in 
Irradiated Rat Lungs
To determine quantitative HSP90ab1 protein expression, 
cytoplasmic protein extracts from lungs were prepared at 
several time points after IR and subjected to western blot-
ting. For comparison, another major HSP, HSP 70, was 
included in the study. The HSP70 protein level remained 
nearly constant after irradiation (Fig. 3A, 3B; Table 1). At 
the same time, HSP90ab1 protein was down-regulated. 
Quantification of total protein using relative intensity (RI) 
showed that total HSP90ab1 was reduced to 0.07 (7%) in 
the rat lung at 12 weeks after irradiation as compared with 
protein levels at 0 weeks after IR (taken as 1.0) (Fig. 3A, 
3C; Table 1). One representative figure of three (HSP90AB1) 
and four (HSP70) independent experiments is shown in 
Figure 3. In order determine the cell types that were affected, 
subsequent IH experiments were performed.
Cellular Distribution of HSP70 and HSP90ab1 
in Normal and Irradiated Lungs
In normal rat lungs, both HSP70 and HSP90ab1 proteins 
were ubiquitously expressed (Fig. 4A–4D), with strong 
expression in type II pneumocytes (red arrows), type I 
pneumocytes (black arrows), alveolar macrophages (most 
cells in the alveolar lumen), bronchial epithelial cells 
(arrowhead with +) and in endothelial cells (arrowhead with 
asterisk). A moderate to low expression level was observed 
in smooth muscle cells of bronchiolar walls (Fig. 4B) and 
blood vessels (Fig. 4B).
In irradiated rat lungs three months after irradiation 
(Fig. 4E, 4F), the same distribution pattern was observed 
for both proteins. However, the HSP90ab1 staining inten-
sity in cells of the alveolar walls, such as type I pneumo-
cytes, endothelial cells (not indicated in Fig. 4) and in 
alveolar macrophages seemed to be reduced. However, 
alveolar macrophages in the irradiated lungs were enlarged, 
formed aggregates (Fig. 1 D–1F; arrows) and had a foamy 
cytoplasm with a granular distribution of both HSP70 and 
HSP90ab1 (Fig. 4E, 4F; asterisks). In contrast to the nor-
mal lung, the irradiated lung contained numerous mast 
cells that were strongly positive for HSP70 protein (Fig. 
4E, arrowheads). Surprisingly, many mast cells contained 
no HSP90ab1, as judged by IH (Fig. 4F, arrowheads). In 
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order to verify that these cells really represented mast cells, 
we performed IF double labelling with the mast cell-spe-
cific enzyme, mast cell tryptase (MCT, Fig. 5). In the nor-
mal rat lung, only single mast cells could be detected 
(see also next paragraph). These mast cells contained no 
detectable or low amounts of HSP70. An example of a sub-
pleural, MCT-positive mast cell of the normal lung (Fig. 
5A–5C) contained very low amounts of HSP70 (Fig. 5B, 
5C). All MCT-positive mast cells detected in the normal 
rat lung contained very low or no HSP90ab1 (Fig. 5D–5F). 
Figure 1. Histology of normal rat lung (A, B) and histopathological changes in the rat lung at 3 months after irradiation (C–F). 
Sections were stained with H&E (A, C, E) and Trichrome (B, D, F) staining. Pathological changes include the accumulation of foamy 
macrophages (arrows) in the alveolar spaces as well as an accumulation of extracellular matrix components (turquoise in D and E). The 
bar corresponds to 50 µm in A, B and 25 µm in C–F.
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In lungs with FA, mast cells (Fig. 5G, 5I, 5K, 5M) were 
strongly positive for HSP70 (Figure 5H, 5I) but were often 
negative for HSP90ab1 (Fig. 5L, 5M). IF double labelling 
with the type I pneumocyte marker aquaporin 5 (aqua 5) 
also confirmed the positivity of type I cells for HSP90ab1 
(Fig. 6A–6C), as did double labelling with the type II pneu-
mocyte marker surfactant protein D (SFTPD) (Fig. 6D–6I). 
These double labelling experiments performed with the 
HSP70 antibody gave the same results (data not shown).
Quantification of Mast Cell Protein Expression
Mast cell quantification of the staining for the protein mark-
ers is given in Table 2. Normal lungs contained only very 
few mast cells, ~8 cells/cm2, in histological sections. 
However, from about 6 weeks after irradiation, a massive 
increase in mast cell number was observed. Irradiated lungs 
at 3 months after irradiation contained about 11,400 mast 
cells/cm2, which corresponds to an approximate 1400-fold 
increase as compared with mast cell counts in control lungs. 
In the normal lungs, mast cells were almost exclusively 
found in the peribronchiolar (peribronchial) or subpleural 
regions. However, in the irradiated lungs, mast cells were 
distributed across all regions of the lung including the alve-
olar walls. At three months after irradiation, mast cells rep-
resented more than one third (37%) of the cells in the rat 
lung and covered 8.5% of the lung tissue. 
In order to determine the relative contribution of mast 
cells to the total amount of HSPs, HSP protein content in 
the total lung was related to the HSP content in mast cells 
(Table 2). The proportion of mast cell HSP70 was 0.26 
(26%) and that of mast cell HSP90ab1, 0.22 (22%). the 
amount of HSP70 in non-mast cells was reduced to 0.79 
(79%) (Table 2). This reveals that the almost constant 
HSP70 levels in the lung at three months after irradiation 
was caused by the emergence of mast cells. Instead, the 
reduction of HSP90ab1 to 0.07 determined in western blot-
ting was slightly lowered to 0.06 by the mast cells that were 
positive for HSP90ab1. Taken together, HSP70 protein was 
slightly reduced whereas HSP90ab1 protein expression was 
more than 10-fold reduced in lung cells other than mast 
cells in radiation-induced FA (Fig. 7, Table 2).
Figure 2. Quantification of HSP90ab1 (HSP90beta) mRNA 
by RT-PCR in total RNA extracts from irradiated rat lungs 
represented as a gel photo from one out of three representative 
experiments (A) and as a diagram representing the values of three 
independent experiments (B). Relative intensities (RI) of western 
blotting bands were corrected against the loading control 
(GAPDH). Error bars represent the SD. HSP90ab1 mRNA was 
decreased to about 60% of the control level at 5.5 weeks after 
irradiation (IR).
Figure 3. Protein levels of HSP70 and HSP90ab1 in irradiated rat 
lungs determined by western blotting using cytoplasmic protein 
extracts of total lungs. (A) Blots for protein samples harvested 
over time for HSP70 and HSP90ab1 as compared with loading 
control (β-actin). (B-C) Relative intensities (RI) of bands after β-
actin correction for HSP70 (B) and HSP90AB1 (C) proteins as 
calculated from western blots. The values of control lungs (0 weeks 
after IR) were arbitrarily set to 1.0. HSP70 is strongly detectable 
in control lungs at all time points after IR, with a slight increase of 
the absolute value at 8 and 12 weeks after IR. HSP90ab1 protein 
was reduced at 8 weeks after IR, and finally at 12 weeks to less 
than 10% of the control level. Three independent experiments 
were performed. Values at 12 weeks after IR—after induction of 
fibrosing alveolitis—ranged from 0.06 to 0.08, with a mean value of 
0.07 as compared with the control level. Error bars represent SD.
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Discussion
In this model of IR-induced FA, previous studies have 
noted major changes in transcription factor activities 
between 4 and 5.5 weeks after irradiation. In particular, 
the activities of the transcription factors Sp1 and AP-1 are 
down-regulated during this time (Haase et al. 2000; Haase 
et al. 2008). This implies that the transcription of Sp1- and 
AP-1-dependent genes would also be down-regulated at 
that time. Thus, we searched for such genes in a subtrac-
tive cDNA library and found HSP90ab1. Indeed, the 
mRNA of HSP90ab1 is down-regulated between 4 and 5.5 
weeks after IR. We also tested the expression changes of a 
member of another big family of HPSs, HSP70, as a con-
trol. Both HSP genes are possible target genes for Sp1 and 
AP-1 since the HSP70 promoter in various species, includ-
ing mouse and man, contains binding sites for these two 
transcription factors (Morgan 1989; Williams et al. 1989). 
The murine HSP90ab1 promoter also contains potential 
binding sites for Sp1 and AP-1 (Dale et al. 1996). 
HSP90ab1 mRNA remains low during the time of obser-
vation, which corresponds to the activities of both Sp1 and 
AP-1 in this model (Haase et al. 2000; Haase et al. 2008). 
One exception to the down-regulation of HSP90ab1 
mRNA occurred at 6.5 weeks after irradiation. We have 
no explanation for this short-term increase, which occurred 
in two of three independent experiments and was not 
accompanied by changes in AP-1 activity (Haase et al. 
2008). The down-regulation of HSP90ab1 protein occurs 
at time points between 6 and 8 weeks after IR, most likely 
after the late mRNA peak at 6.5 weeks. The down-regula-
tion of HSP90ab1 was unexpected since radiation damage 
induces cellular stress, including stress caused by radiation-
induced mutations. HSPs function to stabilize mutated 
proteins (Rutherford & Lindquist 1998; Yahara 1999); 
therefore, one would expect an adaptive increase of all 
HSPs after irradiation. But despite the increased cellular 
stress, we observed the opposite for HSP90ab1. The 
down-regulation of HSP90ab1 suggests that, in radiation-
damaged tissue, the stability of altered proteins might be 
even lower compared with that of control tissue. It is sus-
pected that the down-regulation of HSP90ab1 is likely 
to aggravate the cellular injuries in radiation-damaged 
tissue.
In contrast to their down-regulation in the long-term 
radiation response, HSPs have been described to be acti-
vated in response to short-term IR and UV radiation 
(Trautinger et al. 1999; Park et al. 2000; Kang et al. 2002). 
The transcription factor Ap-1, like many acute-phase 
response genes, is also up-regulated shortly after irradiation 
(Hallahan et al. 1995; Prasad et al. 1995; Hallahan et al. 
1996; Usenius et al. 1996; Martin et al. 1997; Shaulian & 
Karin 1999). This is another indication that the level of HSP 
expression is likely to be regulated by AP-1. These data also 
demonstrate that the short- and long-term responses to ion-
izing radiation are fundamentally different at the molecular 
level concerning their regulation by transcription factors 
and HSPs. In line with its protective role during cellular 
stress, it has been demonstrated that induction of HSP70 
protects against bleomycin-induced pulmonary fibrosis 
(Fujibayashi et al. 2009). However, there is no uniform 
mechanism for all types of fibrosis. In a model of ureteral 
obstruction-mediated renal fibrosis, the HSP90 inhibitor 
17-allylamino-17-demethoxygeldanamycin (17AAG) inhib-
ited renal fibrosis that occurred 2 weeks after the injury 
(Noh et al. 2012). Both the time course of the changes 
(2 weeks versus 8 weeks) and the likely different role of 
HSP90 suggest the involvement of other regulatory mole-
cules in the pathogenesis of fibrosis induced by mechanical 
damage versus radiation-mediated damage.
In our library, we did not detect Hsp47, which has been 
described elsewhere to be overexpressed in various fibros-
ing disorders such as bleomycin-induced pulmonary fibro-
sis (Razzaque et al. 1998b; Ishii et al. 2003; Kakugawa 
et al. 2004) and idiopathic fibrotic lung diseases (Razzaque 
et al. 1998a; Iwashita et al. 2000; Kakugawa et al. 2005). 
One possible reason is the fact that we did not construct a 
library that compared normal lungs to lungs with full-
blown fibrosis. Instead, our library was aimed at detecting 
proteins that were down-regulated at 5.5 weeks after irra-
diation as compared with that at 4 weeks after irradiation, 
since major regulatory changes occur around this time 
period (Haase et al. 2008).
Using IH and IF, we demonstrated that, in normal rat 
lungs, some mast cells contain low amounts HSP70. In 
addition, the level of HSP90ab1 is very low to not detect-
able in mast cells of both normal lungs and in a portion of 
Table 1. Results of the Quantifications of the Western Blots Represented as Relative Intensity in Lungs after Irradiation (IR) 
Compared with Control Lungs (0 weeks after IR).
Weeks After IR HSP70 Mean HSP70 SD HSP90ab1 Mean HSP90ab1 SD
 0 1.00 0.00 1.00 0.00
 4 0.82 0.35 0.90 0.15
 6 1.01 0.42 0.78 0.45
 8 1.12 0.53 0.30 0.31
12 1.06 0.52 0.07 0.01
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mast cells in radiation damaged lungs. This was unex-
pected as not merely the presence but the maintenance of 
high levels of molecular chaperones has been described to 
be necessary for cell survival in both prokaryotic and 
eukaryotic cells (Borkovich et al. 1989; Sreedhar et al. 
2003). Mast cells especially were expected to contain a 
high amount of HSPs because they are rich in proteases 
and signaling proteins that are possibly required to be 
Figure 4. Immunohistochemistry (IH) demonstrated positive HSP70 (A, C, E) and HSP90ab1 (B, D, F) protein expression (brown) in 
normal lungs (A–D) and lungs with fibrosing alveolitis (FA) at three months after irradiation (E, F). Most cell types were positive for both 
proteins including bronchial epithelial cells (arrowheads with +), endothelial cells (arrowheads with asterisk), type I (black arrows) and 
type II (red arrows) pneumocytes, as well as foamy alveolar macrophages (asterisks). Mast cells in irradiated lungs (arrowheads) were 
positive for HSP70 (E) but negative for HSP90ab1 (F). The bar corresponds to 50 µm in A, 16 µm in B, 10 µm in C–F.
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stabilized by chaperones (Caughey 1994; Haase et al. 
2004). In the lung specimens examined, no other cell type 
was found to be negative for HSP70 and HSP90ab1. As a 
compensation for the low amount of expression, part of 
the function of HSP90ab1 might be taken over by other 
isoforms such as HSP90aa1 or, in the irradiated lung, by 
members of the HSP70 family. Yet, HSP70 proteins cannot 
completely fulfill the functions of HSP90 proteins (Wegele 
et al. 2004; Young et al. 2004). In any case, the lack of 
HSP90ab1 and the partial lack of HSP70 is a phenomenon 
Figure 5. Immunofluorescence (IF) double staining for HSP70 or HSP90ab1 expression (green) and mast cell tryptase (MCT, red) in 
normal rat lungs (A–F) and rat lungs with fibrosing alveolitis (FA) at three months after irradiation (G–M). (A–C) In the normal rat lung, 
a subpleural mast cell was specifically labeled with mast cell tryptase (MCT; red), but contained very low amounts of HSP70 (green). 
(D–F) MCT-positive mast cell of the normal lung was negative for HSP90ab1 (green), except for some very weak, speckled cytoplasmic 
staining. (G–M) In rat lungs with fibrosing alveolitis, MCT-positive mast cells (arrows) contained high amounts of HSP70 (H) but were 
often negative for HSP90ab1 (L; arrows). Type I pneumocytes (L, M; arrowheads with asterisk), however, were positive for HSP90ab1. 
Nuclei were counterstained with DAPI. The bar corresponds to 4.5 µm in A–F and 10 µm in G–M.
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that has not been described for any other cell type. Further 
studies should clarify whether the lack of specific HSPs is 
restricted to mast cells in this model and focus on the con-
sequences of HSP90ab1 (and, in part, HSP70) deficiency 
for the function of specific proteins.
Two subpopulations of mast cells have been described: 
mucosal mast cells (MMCs) and connective tissue mast 
cells (CTMCs) (Wilkes et al. 1992). Since we found mast 
cells in the normal lung that were negative as well 
as moderately positive for HSP70, these mast cells may 
represent different subtypes of mast cells or different func-
tional states of one subtype. In our model, most of the mast 
cells in the normal lungs were observed in the deep peri-
bronchiolar region or in the subpleural tissue. Therefore, 
the CTMCs seem to be the dominant type. This finding is 
in favor of the view that the different content of HSP70 
represents different functional states. In contrast to normal 
lungs, all mast cells (>99%, as judged by the co-localization 
Figure 6. IF double staining of normal rat lung for type I and type II pneumocytes. Aquaporin 5 (aqua 5, red in A, C) and HSP90ab1 
(green in B and C) double staining demonstrated that type I pneumocytes were positive for HSP90ab1 (arrows). Double staining of 
type II pneumocyte marker surfactant protein D (SFTPD; red in D, F, G, I) and HSP90ab1 (green in E, F, H, I) demonstrated that type II 
pneumocytes were also positive for HSP90ab1 (arrowheads). Nuclei were counterstained with DAPI. The bar corresponds to 14 µm.
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of MCT-positive and HSP70-positive cells) from radiation-
damaged lungs were strongly positive for HSP70 protein. 
This may be the result of three different processes or a 
combination thereof: (I) HSP70 is up-regulated in all mast 
cells of the lung following radiation damage; (II) there is a 
selective expansion of HSP70-positive pulmonary mast 
cells and an additional up-regulation of HSP70 in these 
cells; or (III) there is a selective accumulation of HSP70-
positive bone marrow-derived mast cells in the radiation-
damaged lung. Further studies are required to clarify this 
question.
In general, mast cells are thought to play an important 
role in pulmonary fibrosis (Broide et al. 1990; Schildge 
et al. 2003). In addition to their release of pro-inflammatory 
cytokines, the mitogenic activity of MCT may be one 
mediator (Ruoss et al. 1991). Therefore, knowledge of the 
specific regulatory mechanisms in mast cells should help to 
gain a better understanding of the pathogenesis of pulmo-
nary fibrosis. In this study, we described some properties of 
mast cells that discriminate them from surrounding cells 
and these findings may help to design targeted therapies for 
pulmonary fibrosis.
Considering the necessity to maintain high levels of 
molecular chaperones HSP70 and HSP90ab1 for cellular 
survival, their decrease in radiation-induced lung damage 
suggests a role for these proteins in the development of FA. 
Mast cells are the only cell type described that can survive 
with low levels of HSP70 and HSP90ab1, which raises the 
question as to which regulatory mechanisms may have 
evolved in these cells to compensate for the low level of 
chaperones.
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